TY - JOUR
T1 - A scoping review on advancements in noninvasive wearable technology for heart failure management
AU - Scholte, Niels T.B.
AU - van Ravensberg, Annemiek E.
AU - Shakoor, Abdul
AU - Boersma, Eric
AU - Ronner, Eelko
AU - de Boer, Rudolf A.
AU - Brugts, Jasper J.
AU - Bruining, Nico
AU - van der Boon, Robert M.A.
N1 - Publisher Copyright:
© The Author(s) 2024.
PY - 2024/10/12
Y1 - 2024/10/12
N2 - Wearables offer a promising solution for enhancing remote monitoring (RM) of heart failure (HF) patients by tracking key physiological parameters. Despite their potential, their clinical integration faces challenges due to the lack of rigorous evaluations. This review aims to summarize the current evidence and assess the readiness of wearables for clinical practice using the Medical Device Readiness Level (MDRL). A systematic search identified 99 studies from 3112 found articles, with only eight being randomized controlled trials. Accelerometery was the most used measurement technique. Consumer-grade wearables, repurposed for HF monitoring, dominated the studies with most of them in the feasibility testing stage (MDRL 6). Only two of the described wearables were specifically designed for HF RM, and received FDA approval. Consequently, the actual impact of wearables on HF management remains uncertain due to limited robust evidence, posing a significant barrier to their integration into HF care.
AB - Wearables offer a promising solution for enhancing remote monitoring (RM) of heart failure (HF) patients by tracking key physiological parameters. Despite their potential, their clinical integration faces challenges due to the lack of rigorous evaluations. This review aims to summarize the current evidence and assess the readiness of wearables for clinical practice using the Medical Device Readiness Level (MDRL). A systematic search identified 99 studies from 3112 found articles, with only eight being randomized controlled trials. Accelerometery was the most used measurement technique. Consumer-grade wearables, repurposed for HF monitoring, dominated the studies with most of them in the feasibility testing stage (MDRL 6). Only two of the described wearables were specifically designed for HF RM, and received FDA approval. Consequently, the actual impact of wearables on HF management remains uncertain due to limited robust evidence, posing a significant barrier to their integration into HF care.
UR - https://www.scopus.com/pages/publications/85206355692
U2 - 10.1038/s41746-024-01268-5
DO - 10.1038/s41746-024-01268-5
M3 - Article
C2 - 39396094
AN - SCOPUS:85206355692
SN - 2398-6352
VL - 7
JO - npj Digital Medicine
JF - npj Digital Medicine
IS - 1
M1 - 279
ER -